Nations Financial Group’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
SCM
PCM
NIM
FHA
RCM
Nations Financial Group's HQL Position: Q1 2026 in Review
Nations Financial Group held its abrdn Life Sciences Investors (HQL) position steady in Q1 2026 at 10,700 shares worth $174K. The position accounts for 0.01% of the portfolio, ranked #745.
Nations Financial Group first reported a position in HQL in Q3 2021 and has held it in 19 quarters since. The position peaked at $243K in Q3 2021. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.
- Nations Financial Group held 10,700 shares of abrdn Life Sciences Investors worth $174K as of Q1 2026.
- Nations Financial Group left its abrdn Life Sciences Investors share count unchanged in Q1 2026.
- abrdn Life Sciences Investors made up 0.01% of Nations Financial Group's portfolio in Q1 2026, its #745 holding.
- Nations Financial Group first reported a position in abrdn Life Sciences Investors in Q3 2021 and has held it in 19 quarters since.
- Nations Financial Group's abrdn Life Sciences Investors position peaked at $243K in Q3 2021.
- 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.
Based on Nations Financial Group's 13F filing for Q1 2026, filed 15 Apr 2026.